BIOLIFE SOLUTIONS INC (BLFS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 60M 120M 180M Q4 '10: 2.1M Q1 '11: 2.2M Q2 '11: 2.3M Q3 '11: 2.5M Q4 '11: 2.8M Q1 '12: 3M Q2 '12: 3.5M Q3 '12: 4.4M Q4 '12: 5.7M Q1 '13: 7M Q2 '13: 8.2M Q3 '13: 8.7M Q4 '13: 8.9M Q1 '14: 8.9M Q2 '14: 7.7M Q3 '14: 6.8M Q4 '14: 6.2M Q4 '17: 11M Q1 '18: 12.5M Q2 '18: 15.1M Q3 '18: 17.4M Q4 '18: 19.7M Q1 '19: 21.7M Q2 '19: 23.2M Q3 '19: 24.5M Q4 '19: 27.4M Q1 '20: 33.8M Q2 '20: 37M Q3 '20: 41.7M Q4 '20: 48.1M Q1 '21: 52.8M Q2 '21: 74.1M Q3 '21: 96.6M Q4 '21: 119.2M Q1 '22: 138.5M Q2 '22: 147.9M Q3 '22: 154.8M Q4 '24: 74.6M Q1 '25: 78.3M Q2 '25: 82M Q3 '25: 88.7M Q4 '25: 92.3M Q1 '26: 97.8M Q2 '26: 102.8M Q1 '11 Q3 '12 Q1 '14 Q2 '18 Q4 '19 Q2 '21 Q4 '24 Q2 '26

Gross Profit TTM

0 6M 12M 18M Q4 '10: 856.4K Q1 '11: 867.9K Q2 '11: 1M Q3 '11: 1.2M Q4 '11: 1.4M Q1 '12: 1.7M Q2 '12: 1.8M Q3 '12: 2M Q4 '12: 2.3M Q1 '13: 2.9M Q2 '13: 3.3M Q3 '13: 3.6M Q4 '13: 3.8M Q1 '14: 3.5M Q2 '14: 3.3M Q3 '14: 3M Q4 '14: 3M Q1 '15: 3M Q2 '15: 3.3M Q3 '15: 3.7M Q4 '15: 3.8M Q1 '16: 4M Q2 '16: 4.3M Q3 '16: 4.6M Q4 '16: 4.8M Q1 '17: 5.1M Q2 '17: 5.6M Q3 '17: 6.3M Q4 '17: 6.7M Q1 '18: 7.8M Q2 '18: 9.8M Q3 '18: 11.6M Q4 '18: 13.5M Q1 '19: 15.2M Q2 '19: 16.3M Q3 '19: 17.1M Q4 '10 Q1 '12 Q2 '13 Q3 '14 Q4 '15 Q1 '17 Q2 '18 Q3 '19

Operating Income TTM

-120M -80M -40M 0 40M 80M 120M Q4 '10: -1.4M Q1 '11: -1.4M Q2 '11: -1.3M Q3 '11: -1.3M Q4 '11: -1.2M Q1 '12: -934.7K Q2 '12: -981.3K Q3 '12: -845.2K Q4 '12: -942.2K Q1 '13: -570.6K Q2 '13: -346.9K Q3 '13: -308.2K Q4 '13: -285.4K Q1 '14: -846.7K Q2 '14: -1.7M Q3 '14: -2.4M Q4 '14: -3.1M Q1 '15: -3.9M Q2 '15: -4.2M Q3 '15: -4.6M Q4 '15: -5M Q1 '16: -5.3M Q2 '16: -5.8M Q3 '16: -5.6M Q4 '16: -4.9M Q1 '17: -3.8M Q2 '17: -2.6M Q3 '17: -1.5M Q4 '17: -1.1M Q1 '18: -452K Q2 '18: 1.2M Q3 '18: 2.4M Q4 '18: 3.7M Q1 '19: 4.1M Q2 '19: 3.6M Q3 '19: 1.6M Q4 '19: -220K Q1 '20: -416K Q2 '20: -1.1M Q3 '20: -1.6M Q4 '20: -6.2M Q1 '21: -7.6M Q2 '21: -12.2M Q3 '21: -22.1M Q4 '21: -35.2M Q1 '22: -42.1M Q2 '22: -114.2M Q3 '22: -114.7M Q4 '23: -17.2M Q1 '24: -6.9M Q2 '24: 2.4M Q3 '24: 17.5M Q4 '24: -4.5M Q1 '25: -1.7M Q2 '25: -16.5M Q3 '25: -16.2M Q4 '25: -16.6M Q1 '26: -16.1M Q2 '26: 1.7M Q2 '11 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '24 Q2 '26

Net Income TTM

-150M -100M -50M 0 50M 100M 150M Q4 '10: -2M Q1 '11: -2.1M Q2 '11: -2M Q3 '11: -2M Q4 '11: -2M Q1 '12: -1.6M Q2 '12: -1.7M Q3 '12: -1.6M Q4 '12: -1.7M Q1 '13: -1.4M Q2 '13: -1.2M Q3 '13: -1.1M Q4 '13: -1.1M Q1 '14: -1.6M Q2 '14: -2.2M Q3 '14: -2.8M Q4 '14: -3.2M Q1 '15: -3.7M Q2 '15: -3.8M Q3 '15: -4M Q4 '15: -4.2M Q1 '16: -4.4M Q2 '16: -4.8M Q3 '16: -4.7M Q4 '16: -6.9M Q1 '17: -6.5M Q2 '17: -5.9M Q3 '17: -5.3M Q4 '17: -2.5M Q1 '18: 3.2M Q4 '20: 2M Q1 '21: -21.4M Q2 '21: 2.8M Q3 '21: 4M Q4 '21: -8.9M Q1 '22: -15.2M Q2 '22: -96M Q3 '22: -106.4M Q4 '22: -139.8M Q1 '23: -146.1M Q2 '23: -83.4M Q3 '23: -102.2M Q4 '23: -68M Q1 '24: -64.5M Q2 '24: -75M Q3 '24: -47.6M Q4 '24: -20.2M Q1 '25: -10.4M Q2 '25: -5.5M Q3 '25: -3.2M Q4 '10 Q3 '12 Q2 '14 Q1 '16 Q4 '17 Q1 '22 Q4 '23 Q3 '25

Cost of Revenue TTM

0 6M 12M 18M Q4 '10: 1.2M Q1 '11: 1.3M Q2 '11: 1.3M Q3 '11: 1.4M Q4 '11: 1.4M Q1 '12: 1.3M Q2 '12: 1.7M Q3 '12: 2.4M Q4 '12: 3.4M Q1 '13: 4.1M Q2 '13: 4.9M Q3 '13: 5.1M Q4 '13: 5.2M Q1 '14: 5.3M Q2 '14: 4.5M Q3 '14: 3.9M Q4 '14: 3.2M Q1 '15: 2.6M Q2 '15: 2.6M Q3 '15: 2.6M Q4 '15: 2.6M Q1 '16: 2.8M Q2 '16: 3M Q3 '16: 3.2M Q4 '16: 3.4M Q1 '17: 3.6M Q2 '17: 3.7M Q3 '17: 3.9M Q4 '17: 4.3M Q1 '18: 4.7M Q2 '18: 5.3M Q3 '18: 5.8M Q4 '18: 6.2M Q1 '19: 6.5M Q2 '19: 6.9M Q3 '19: 7.4M Q4 '19: 8.8M Q1 '20: 11.7M Q2 '20: 14.2M Q3 '20: 16.9M Q4 '11 Q1 '13 Q2 '14 Q3 '15 Q4 '16 Q1 '18 Q2 '19 Q3 '20

Operating Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q2 '11: -1.1M Q3 '11: -1.1M Q4 '11: -989.9K Q1 '12: -760.1K Q2 '12: 239.9K Q3 '12: 493.3K Q4 '12: 854.9K Q1 '13: 803.3K Q2 '13: 248.9K Q3 '13: 236.3K Q4 '13: 146K Q1 '14: -621.6K Q2 '14: -1.7M Q3 '14: -2.4M Q4 '14: -3.2M Q1 '15: -3.6M Q2 '15: -3.9M Q3 '15: -4.4M Q4 '15: -5M Q1 '16: -5.3M Q2 '16: -5.2M Q3 '16: -4.9M Q4 '16: -4.3M Q1 '17: -2.9M Q2 '17: -1.8M Q3 '17: -866K Q4 '17: 605K Q1 '18: 1.2M Q4 '18: 2.3M Q1 '19: 3.1M Q4 '20: 6.6M Q1 '21: 7.8M Q2 '21: -4.1M Q3 '21: -1.6M Q4 '21: -4.6M Q1 '22: -14.3M Q2 '22: -16.5M Q3 '22: -17.1M Q4 '22: -8.5M Q1 '23: -3.3M Q2 '23: -1.1M Q3 '23: -7M Q4 '23: -12.5M Q1 '24: -14.3M Q2 '24: -84K Q3 '24: 9.1M Q4 '24: 8.4M Q1 '25: 14.6M Q2 '25: 15.5M Q3 '25: 16.8M Q4 '25: 20.1M Q1 '26: 17.9M Q2 '26: 16.9M Q1 '12 Q4 '13 Q3 '15 Q2 '17 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow TTM

-27M -18M -9M 0 9M 18M 27M Q2 '11: -1.2M Q3 '11: -1.2M Q4 '11: -1.1M Q1 '12: -887.4K Q2 '12: -833.6K Q3 '12: -714.7K Q4 '12: -296.8K Q1 '13: -335.2K Q2 '13: -105.3K Q3 '13: 21.3K Q4 '13: -90.7K Q1 '14: -843.2K Q2 '14: -1.8M Q3 '14: -2.6M Q4 '14: -3.8M Q1 '15: -4.2M Q2 '15: -4.5M Q3 '15: -4.8M Q4 '15: -5.1M Q1 '16: -5.4M Q2 '16: -5.4M Q3 '16: -5.1M Q4 '16: -4.5M Q1 '17: -3.1M Q2 '17: -1.9M Q3 '17: -970.9K Q4 '17: 461K Q1 '18: 1M Q4 '18: 1.8M Q1 '19: 2.5M Q4 '20: 4.7M Q1 '21: 4.2M Q2 '21: -10.3M Q3 '21: -10M Q4 '21: -13M Q1 '22: -22.5M Q2 '22: -24M Q3 '22: -24.6M Q4 '22: -18.9M Q1 '23: -15.5M Q2 '23: -11.9M Q3 '23: -16.8M Q4 '23: -18.9M Q2 '11 Q4 '12 Q2 '14 Q4 '15 Q2 '17 Q4 '20 Q2 '22 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '17: 13.1M Q3 '17: 13.2M Q1 '18: 14.1M Q2 '18: 20.4M Q3 '18: 23.7M Q1 '19: 18.6M Q2 '19: 24.5M Q3 '19: 25.3M Q1 '20: 21M Q2 '20: 23.3M Q3 '20: 31.6M Q1 '21: 33.2M Q2 '21: 40.4M Q3 '21: 43.3M Q1 '22: 42M Q2 '22: 42.5M Q3 '22: 42.6M Q1 '23: 43M Q2 '23: 43.4M Q3 '23: 43.6M Q1 '24: 45.4M Q2 '24: 46M Q3 '24: 46.2M Q1 '25: 48.4M Q2 '25: 47.8M Q3 '25: 48.7M Q1 '26: 49.2M Q2 '26: 49.3M Q2 '18 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '11: -0.04 Q3 '11: -0.04 Q4 '11: -0.04 Q1 '12: -0.03 Q2 '12: -0.03 Q3 '12: -0.03 Q4 '12: -0.33 Q1 '13: -0.33 Q2 '13: -0.38 Q3 '13: -0.43 Q4 '13: -0.22 Q1 '14: -0.32 Q2 '14: -0.33 Q3 '14: -0.34 Q4 '14: -0.32 Q1 '15: -0.31 Q2 '15: -0.32 Q3 '15: -0.34 Q4 '15: -0.35 Q1 '16: -0.36 Q2 '16: -0.39 Q3 '16: -0.38 Q4 '16: -0.55 Q1 '17: -0.52 Q2 '17: -0.47 Q3 '17: -0.42 Q4 '17: -0.21 Q1 '21: -0.84 Q2 '21: 0.05 Q3 '21: 0.09 Q4 '21: -0.24 Q1 '22: -0.39 Q2 '22: -2.30 Q3 '22: -2.54 Q4 '22: -3.25 Q1 '23: -3.39 Q2 '23: -1.90 Q3 '23: -2.33 Q4 '23: -1.55 Q1 '24: -1.45 Q2 '24: -1.67 Q3 '24: -1.04 Q4 '24: -0.44 Q1 '25: -0.22 Q2 '25: -0.10 Q3 '25: -0.05 Q1 '12 Q3 '13 Q1 '15 Q3 '16 Q1 '21 Q3 '22 Q1 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.